DiRocco Derek
SEC insider (Form 3/4/5 filer). CIK 0001792061. Director at Acrivon Therapeutics, Inc. (ACRV) and 3 other issuers. 13 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in WATERTOWN, MA.
Companies DiRocco Derek has filed insider reports for
- Acrivon Therapeutics, Inc. (ACRV): Director
- Mineralys Therapeutics, Inc. (MLYS): Director
- Evommune, Inc. (EVMN): Director
- 89bio, Inc. (ETNB): Director
DiRocco Derek
CIK: 0001792061
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 17, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
20.3K shares- - May 18, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirect9.4K shares- - Feb 19, 2026MLYS
Mineralys Therapeutics, Inc.
AwardDirect6.2K shares- - Oct 30, 2025ETNB
89bio, Inc.
DispositionIndirectStock Option (Right to Buy)
12.5K shares- - Oct 30, 2025ETNB
89bio, Inc.
DispositionDirectStock Option (Right to Buy)
25K shares- - Oct 30, 2025ETNB
89bio, Inc.
DispositionDirectStock Option (Right to Buy)
45.2K shares- - Oct 30, 2025ETNB
89bio, Inc.
DispositionDirectStock Option (Right to Buy)
56.4K shares- - Oct 30, 2025ETNB
89bio, Inc.
DispositionDirectStock Option (Right to Buy)
27.4K shares- - Oct 30, 2025ETNB
89bio, Inc.
DispositionDirectStock Option (Right to Buy)
7K shares- - Oct 30, 2025ETNB
89bio, Inc.
DispositionIndirectStock Option (Right to Buy)
7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 20,275 | - | - | Direct |
| May 18, 2026 | ACRV Acrivon Therapeutics, Inc. | Award | 9,366 | - | $0 | Direct |
| Feb 19, 2026 |  MLYS Mineralys Therapeutics, Inc. | Award | 6,200 | - | $0 | Direct |
| Oct 30, 2025 |  ETNB 89bio, Inc. | Disposition Stock Option (Right to Buy) | 12,500 | - | - | Indirect |
| Oct 30, 2025 | ETNB 89bio, Inc. | Disposition Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| Oct 30, 2025 | ETNB 89bio, Inc. | Disposition Stock Option (Right to Buy) | 45,150 | - | - | Direct |
| Oct 30, 2025 | ETNB 89bio, Inc. | Disposition Stock Option (Right to Buy) | 56,400 | - | - | Direct |
| Oct 30, 2025 | ETNB 89bio, Inc. | Disposition Stock Option (Right to Buy) | 27,400 | - | - | Direct |
| Oct 30, 2025 | ETNB 89bio, Inc. | Disposition Stock Option (Right to Buy) | 7,000 | - | - | Direct |
| Oct 30, 2025 | ETNB 89bio, Inc. | Disposition Stock Option (Right to Buy) | 7,000 | - | - | Indirect |
1-10 of 13 transactions